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Abstract: Screening and early diagnosis are the key factors for the reduction of mortality rate 
and treatment cost of cancer. Therefore, sensitive and selective methods that can reveal the low 
abundance of cancer biomarkers in a biological sample are always desired. Here, we report the 
development of a novel electrochemical biosensor for early detection of breast cancer by using 
bioconjugated self-assembled pH-responsive polymeric micelles. The micelles were loaded with 
ferrocene molecules as “tracers” to specifically target cell surface-associated epithelial mucin 
(MUC1), a biomarker for breast and other solid carcinoma. The synthesis of target-specific, 
ferrocene-loaded polymeric micelles was confirmed, and the resulting sensor was capable of 
detecting the presence of MUC1 in a sample containing about 10 cells/mL. Such a high sen-
sitivity was achieved by maximizing the loading capacity of ferrocene inside the polymeric 
micelles. Every single event of binding between the antibody and antigen was represented by the 
signal of hundreds of thousands of ferrocene molecules that were released from the polymeric 
micelles. This resulted in a significant increase in the intensity of the ferrocene signal detected 
by cyclic voltammetry.
Keywords: electrochemical immunoassay, polymeric nanoparticles, breast cancer biomarkers, 
biosensors
Introduction
Breast cancer is still one of the principal causes of cancer mortality in women. How-
ever, there has been a continued decline in death rates over the last decades due to the 
incremental advances in the medical field, despite an increasing incidence of breast 
cancer. Therefore, preventive screening and early diagnosis are vital components of 
a comprehensive cancer control program. Immunoassays are widely used as analyti-
cal tools in clinical and pharmaceutical fields to detect and quantify biomolecules 
in mixtures such as serum or urine through the use of an immunoglobulin.1,2 Such 
tests employ an array of different signaling molecules to allow the detection of the 
antibody–antigen interaction. These signaling molecules are usually chemically con-
jugated to the desired antibody or antigen. Currently, enzymatic signaling molecules 
are most widely used in immunoassays (eg, enzyme-linked immunosorbent assay, 
ELISA).3 These enzymes enable detection due to change in color in the presence of 
certain enzymatic substrates. Alternatively, detection can be achieved through the 
enhancement of the generated chemiluminescence signal; it was reported that up to 
1000-fold signal improvement can be achieved in the presence of certain molecules 
such as horseradish peroxidase.4,5 Other signaling mechanisms reported include the 
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use of fluorescence dye molecules,6 radioactive isotopes,7 
DNA reporters,8,9 and fluorogenic reporters.10,11
Electrochemical detection is considered as one of the 
most reliable and efficient techniques to detect biomolecules 
within biological samples.12 However, the implementation of 
this method in the field of immunoassay remains very limited 
compared to optical detection systems. Although several 
attempts were made in the past by scientists to develop immu-
nosensors using enzymes that convert an enzyme substrate 
into an electrochemically measurable product, efforts so far 
have yielded no method that can rival the existing systems. 
This limitation was mostly attributed to the difficulty in 
achieving an acceptable level of signal-to-noise ratio due 
to the following reasons: 1) nonspecific adsorptions of the 
enzymes occur within the detection vicinity; and 2) most 
of the antibody-binding capability is often lost during the 
immobilization step because of the nonspecific antibody 
adsorption on the electrode surface. Therefore, these limita-
tions usually dramatically affect the reliability of the immu-
noassay. Gehring et al13 developed an amperometric assay 
for the detection of Salmonella typhimurium cells which were 
apprehended using conjugated magnetic beads. The beads 
were then coated on graphite electrodes, and the alkaline 
phosphatase (AP)-labeled goat anti-Salmonella antibody cat-
alyzed the production of an electroactive para-aminophenol 
from its substrate, para-aminophenyl phosphate, which 
was monitored electrochemically. The obtained signal was 
directly related to the number of bacterial cells, and the sen-
sor had a sensitivity of 8×103 cells/mL.
Thus, to overcome such inconveniences, liposomes 
encapsulated with marker molecules or enzymes have been 
used.14 However, the main downside of liposomes is their 
instability throughout their use or storage,15 which is mainly 
related to their surface properties. Several solutions were 
investigated to improve liposome stability. For example, the 
modification of the composition of the liposome lipids via the 
incorporation of a bio-adhesive molecule such as chitosan or 
cholesterol in their membrane significantly improved their 
stability,16 and also, the cross linking of the hydrophobic 
core of the liposome membrane via polymerization,17 or 
through surface-active polymer additives,18 has shown posi-
tive effect on their stability. So far, such improvements have 
been revealed to be very costly and increase the complexity 
of the fabrication process of these liposome immunoassays 
which cause them to be less efficient even with enhanced 
sensitivity range. Another major concern with using con-
ventional liposomes in immunoassay is leakage, especially 
in the case of low-abundance protein detection. It was found 
that when small molecules are encapsulated inside liposome 
as “tracers”, these molecules have the tendency to leak into 
the outside medium. Such a problem can greatly affect the 
performance of the immunoassay.19,20
Therefore, developing a method that does not involve 
antibody immobilization on an electrode surface or rely on 
enzymatic reactions to generate the electrochemical signal 
is highly in demand. Such methods should provide a more 
robust and stable carrier which will present an important leap 
toward a more efficient and reliable biosensor for medical 
and food safety applications. Electrochemical immunoas-
says based on loaded pH-sensitive polymeric micelles offer 
an attractive alternative over the existing procedures, espe-
cially in applications where high selectivity, sensitivity, and 
stability are needed.
In this work, the MUC1 glycoprotein (protein at the 
cell surface) was selected as a target for our new biosensor 
because it is frequently overexpressed in human cancers, 
particularly in breast cancer.21 In addition, MUC1 has shown 
a great potential for early detection and grading of tumors, 
along with the tumor responses to therapy. Furthermore, cell 
surface-associated epithelial mucin (MUC1) has been tested 
as a target for gold nanoparticle-mediated cancer diagnosis 
and therapy.22–24
MUC1 is a high-molecular-weight plasma membrane-
bound protein with an obtruding O-glycosylated N-terminal 
domain that overhangs from the apical surface of glandular 
epithelial cells in the breast, colon, and lung.25 MUC1 has 
72-aa C-terminal domain and a single transmembrane domain 
and is regulated and cleaved by tyrosine phosphorylation.26
In this paper, we report the development of an exceed-
ingly sensitive and fast bioassay to probe and quantify bio-
markers (breast cancer biomarker). Since these polymeric 
nanoparticles have been shown to be efficient and stable 
carriers for hydrophobic molecules, we encapsulated tracer 
signal generator molecules (ferrocene) inside these poly-
meric nanoparticles, and upon their release, the ferrocene 
molecules acted as signal amplifiers for the binding between 
the antibody and antigen.
Experimental section
reagents and materials
Ethanol (96%, v/v) from AGA, HPLC-grade tetrahydro-
furan (THF) from Sigma, hydrochloric acid (37%, w/w), 
MTT, Trizol reagent paraformaldehyde, and methoxy-
polyethylene glycol N-hydroxysuccinimide ester from 
Sigma-Aldrich were used. Monoclonal antibodies against 
the human MUC1 protein, SM3 (Abcam), and C595 (Santa 
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Cruz Biotechnology) were obtained. THF (HPLC grade) 
from Ridel-de-Haën, hydrochloric acid (37%) from Merck, 
N,N-dimethylformamide (DMF), isopropanol from BDH 
Prolabo, methoxypolyethylene glycol N-hydroxysuccinimide 
ester and paraformaldehyde from Sigma-Aldrich, MTT 
from Applichem, and Trizol reagent from Invitrogen were 
also used. For cell culture, complete Dulbecco’s Modified 
Eagle’s Medium or RPMI1640 culture media (DMEM 
or RPMI1640 basic medium [Lonza] supplemented with 
10% fetal bovine serum [FBS; PAA], 2 mM glutamine, 
100 units/mL penicillin, and 100 μg/mL streptomycin) was 
prepared. Cell lines were acquired commercially; MCF-7 
from ATCC (ATCC HTB-22) and MDA-MB-468 from 
ATCC (ATCC HTB-132).
equipment
For 1H nuclear magnetic resonance (NMR) experiments, 
Bruker ARX 400 was used, while spectrofluorometer 
(Jobin Yvon – HORIBA Scientific) was used for measuring 
fluorescence spectra. All emission spectra were obtained 
using 1-cm quartz cuvettes at λ =334 nm (Hellma Quartz-
Suprasil). White-light and fluorescence images of living 
cells were obtained via Leica DM IL inverted fluorescence 
microscope coupled to a digital CCD camera. Light scatter-
ing experiments were performed using Brookhaven Instru-
ments BI-200SM multi-angle particle size analyzer utilizing 
dynamic light scattering (DLS) and static light scattering 
(SLS) modes.
synthesis of the poly(ethylene glycol-
b-trimethylsilyl methacrylate) (Peg-b-
PTMsMa)
In nitrogen-charged Schlenk tube, 0.8 g of macro-CTA was 
dissolved in 10 mL THF. Then, 0.030 g of azobisisobuty-
ronitrile (AIBN) and 3.5 mL of trimethylsilyl methacrylate 
(TMSMA) were added. After that, the mixture was placed in 
an oil bath under stirring at 60°C for 24 h. The mixture was 
then cooled down, and 10 mL of THF was added to dilute the 
mixture. After solvent evaporation, the obtained crude was 
dissolved in methanol, and the polymer was recovered via 
precipitation upon the addition of water. A white solid was 
obtained and dried under vacuum at 60°C overnight, yield-
ing 2 g (55%) of the polymer. 1H NMR (dimethylsulfoxide, 
DMSO) δ 0.055 (s, (CH
3
)
3
Si), 1.096 (s, CH
3
C–C=O), 1.277 
(s, CH
3
C–C=O), 1.778 (s, CH
2
C–C=O), 1.890 (s, CH
2
C–
C=O), 3.256 (s, CH
3
O–(CH
2
CH
2
O)
n
), 3.54 (s, (CH
2
CH
2
O)
n
), 
and 4.560 (q, CH
3
CH
2
O–C=S). DP
n
 (NMR) =45. Gel per-
meation chromatography (GPC) analysis exposed only one 
modal molecular weight distribution, from which a value of 
M
n
 =9 kDa27 was deducted.
Preparation of loaded polymeric 
nanoparticles
Loaded polymeric nanoparticles were prepared as follows: 
30 mg of PEG-b-PTMSMA and 0.5 mg of either 
1-methylpyrene (as fluorophore) or ferrocene (as electro-
chemical active complex) were dissolved in 0.3 mL of 
DMF. The mixture was stirred for a period of 3 h at room 
temperature. Next, 1.0 mL of Milli-Q water was added to the 
solution at a rate of one drop every 10 s to induce the micel-
lization. The resulting mixture was then dialyzed against 
Milli-Q water for 3 days at 25°C (water was replaced twice 
a day). A dialysis cassette with 10 kDa cut-off capability was 
used to remove any un-encapsulated molecules and non-self-
assembled polymer molecules from the mixture.
Preparation of bioconjugated magnetic 
beads with anti-MUc1 (sM3)
One hundred micrograms of anti-MUC1 antibodies was 
added to 500 μL tosylactivated magnetic beads (9×108 beads) 
in 0.1 M borate buffer (pH 9.5). The mixture was mixed for 
12 h under slow tilt rotation at 40°C. Unreacted anti-MUC1 
antibodies were then washed off using magnetic separa-
tion. Subsequently, the magnetic beads were washed with 
phosphate-buffered saline (PBS) (pH 7.4) containing 0.1% 
(w/v) bovine serum albumin (BSA) for 20 min at 40°C, fol-
lowed by deactivating the remaining tosylactivated magnetic 
beads with 0.4 M Tris buffer (pH 8.5) containing 0.1% (w/v) 
BSA. The obtained bioconjugated magnetic beads were 
washed with PBS buffer (pH 7.4).
Bioconjugation of polyethylene glycol 
with MUc1 antibodies
Bioconjugation of polyethylene glycol with C595 mAb was 
achieved by adding 4 mg of methoxypolyethylene glycol 
N-hydroxysuccinimide ester to a solution containing 3 μg of 
C595 mAb in 500 μL of 0.1 M bicarbonate buffer (pH 8.3). 
The mixture was softly stirred for 3 days under slow tilt 
rotation at 4°C.28,29
Preparation of loaded bioconjugated 
micelles with c595
Twenty milligrams of PEG-b-PTMSMA block copolymer 
and 0.5 mg of ferrocene were dissolved in 0.5 mL of the 
freshly prepared biotin-PEO (MUC1 antibodies-PEO). The 
solution was agitated for 3 h at 25°C. Then, 2 mL of water 
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was added to the mixture at a rate of 10 μL every 10 s to 
stimulate the micellization. The resulting mixture was then 
placed in a dialysis cassette of 10 kDa molecular weight cut-
off and dialyzed against Milli-Q water for 3 days at 25°C 
(water was replaced twice a day). After that, the solution 
was diluted five times with PBS buffer. The presence of the 
antibody on the micelles (polymeric nanoparticles) was tested 
using ELISA (data not shown).
cell lines
The MCF-7 (human breast adenocarcinoma) and S17 
(mouse bone marrow stroma) cell lines and MDA-MB-468 
(human breast adenocarcinoma) were kept in DMEM cul-
ture medium. Cells were cultured at 37°C under humidified 
atmosphere of 5% CO
2
.
cell culture
The MCF-7 and MDA-MB-468 and S17 adherent cell lines 
were kept in DMEM culture medium complemented with 
10% FBS, 200 mM glutamine, 10,000 units/mL penicillin, 
and 10,000 μg/mL streptomycin. All cell culture incubations 
were performed at 37°C under humidified atmosphere of 5% 
CO
2
. Cells were thawed at 37°C and pipetted into 10 mL 
of prewarmed medium. Next, the cells were centrifuged at 
300× g for 5 min to eliminate DMSO. Then, the supernatant 
was discarded, and the pellets of cells were resuspended 
in 2 mL of fresh medium. The cells were seeded into T25 
flasks, and 8 mL of the medium was added for a final volume 
of 10 mL. The medium was changed every 2 days. For cell 
count, medium was first removed from the flask, cells were 
washed with warm PBS, and then 1 mL of 0.25% trypsin 
was added per 59 cm2 to detach the cells. Cells were allowed 
to detach for 1–5 min (depending on the cell line) at 37°C. 
DMEM was added to the flask to deactivate the trypsin, 
before transferring the cells to a 15 mL centrifuge tube. 
Cells were centrifuged at 300× g for 5 min, and the pellet 
was resuspended in 1 mL medium for cell count. The cell 
pellet was dissociated by pipetting gently up and down to 
get a single cell suspension.
Thirty microliters of 0.4% trypan blue was added to 30 μL 
of cell suspension. Then, 10 μL of the cells with trypan blue 
was loaded on each side of a hemocytometer. Viable cells 
that did not take up the trypan blue were counted on an 
inverted light microscope. The cells were counted in four 
1 mm2 squares. The equation to calculate the cell number 
per cubic millimeter is:
 
Cell number/mm3 =  Number of cells counted per square 
millimeter × Dilution used × 10  
Testing the selectivity of the polymeric 
micelle toward cancer cells
Seeded MCF-7 cells in culture plates were allowed to attach 
for 24 h at 37°C. Polymeric nanoparticles bioconjugated with 
C595 or SM3 antibody and loaded with fluorescence dye 
(1-methylpyrene) were added to the cell culture and allowed 
to incubate for 1 h at 37°C. As a control, we used unlabeled 
1-methylpyrene-loaded polymeric nanoparticles. Surplus of 
the polymeric nanoparticles was eliminated via washing three 
times with PBS buffer. Both the cell lines (S17 and MCF-7) 
were grown together on glass cover slips (at a ratio of 5 to 1). 
The cells were then allowed to attach for a period of 24 h at 
37°C. The 1-methylpyrene-loaded and bioconjugated poly-
meric nanoparticles with MUC1 were added to the cells and 
incubated for 1 h at 37°C. Then, the cells were washed three 
times with PBS buffer and fixed with 4% paraformaldehyde 
for 40 min. Next, the cover slip was mounted and observed 
under a fluorescence microscope.
Preparation of MUc1 biomarker
The S17 (mouse bone marrow stroma) and MCF-7 (human 
breast adenocarcinoma) cells in DMEM culture medium 
were separately detached into single cells by incubating 
with trypsin–ethylene diamine tetraacetic acid for 10 min at 
37°C. The cells were shaken off, washed three times with 
PBS buffer, and centrifuged at 3,000 rpm for 4 min. S17 
and MCF-7 cells were then resuspended in 2 mL of mem-
brane buffer comprising protease inhibitors and then lysed 
by means of nitrogen disruptor at 500 psi for 15 min. The 
purified supernatants were used for bioassay.
Detection of breast cancer biomarker
Different concentrations of cells for MCF-7 and S17 cell 
lysis were prepared (1,000, 100, and 10 cells/mL) and 
separately incubated along with 20 μL of SM3-coated 
magnetic beads for a period of 1 h under slow tilt rotation 
at 4°C. After incubation, the unbound MUC1 was removed 
by washing the beads four times with PBS buffer using 
magnetic separation.
Next, 200 μL of the polymeric nanoparticles conjugated 
with anti-MUC1 was added to the bioconjugated magnetic 
beads. The mixture sandwich magnetic beads (beads–SM3–
MUC1) and bioconjugated polymeric micelles were stirred 
for 1 h by slow tilt rotation at 4°C. The unbound biocon-
jugated polymeric nanoparticles were washed off using 
magnetic separation. After washing the beads four times 
with PBS buffer, the ferrocene molecules were released 
from the polymeric micelles by decreasing the pH to 5. 
The redox signal of the released ferrocene molecules inside 
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the electrochemical cell was measured and recorded using 
Autolab potentiostat (Metrohm Autolab).
electrochemistry experiments
Electrochemistry experiments were performed using 
cyclic voltammetry (CV) in a one-compartment cell with 
three-electrode formation using potentiostat with GPE and 
FRA software programs (Autolab PG-30). The working elec-
trode (WE) used in this experiment was platinum disc elec-
trode (10 μm diameter) and the counter electrode employed 
was platinum gauze, while the reference electrode (RE) was 
made from saturated calomel. The three electrodes were 
regularly rinsed with distilled water and allowed to dry under 
argon before inserting them in the electrochemical cell. The 
built-in Luggin capillary allowed the positioning of the RE as 
close as possible to the WE with the intention of reducing the 
uncompensated solution resistance. The cathodic (E
pc
) and 
anodic (E
pa
) peaks of ferrocene (Fe(C
2
H
5
)
2
+/Fe(C
5
H
5
)) were 
achieved at a scan rate of 0.10 V/s.
Results and discussion
Preparation of polymeric micelles
pH-sensitive polymeric nanoparticles have gained a great deal 
of attention in the fields of drug delivery and medical imaging 
in part due to their great stability and their high encapsulation 
capacity within their core, of a wide variety of molecules, 
during self-assembly into micelles (Scheme 1).30,31
Such polymers bear silicon moieties as acid-labile groups 
that can be cleaved under mild acidic conditions of pH (5–6), 
rendering the polymer hydrophilic. This causes the poly-
meric particles to disintegrate and eventually release their 
contents. PEG-b-PTMSMA was produced using reversible 
addition-fragmentation chain transfer from TMSMA using 
(O-ethylxanthate)-methylPEG as a macro-chain transfer 
agent and AIBN as a radical initiator.
The polymer was characterized by 1H NMR spectroscopy 
and triple-detection GPC. A DP
n
 of 45 was deduced from 
the NMR peak area at 3.54 ppm (CH
2
 in PEG) and that at 
1.09 ppm (CH
3
 in TMSMA). GPC analysis disclosed only 
one-mode molecular weight distribution, from which the 
value of M
n
 =9 kDa was calculated. Both the NMR and 
Fourier transform infrared spectra indicated the presence of 
TMSMA units via the singlet at 0.056 ppm corresponding to 
(CH
3
)
3
Si and the bands at 1,259, 1,178, and 840 cm-1 that were 
consistent with the group Si(CH
3
)
3
. On the matrix-assisted 
laser desorption/ionization time of flight spectrum, the inter-
peak distances matching the masses of both repeating units 
were 158 for TMSMA and 44 for ethylene glycol.
The preparation of native and dye-encapsulated PEG-b-
PTMSMA nanoparticles was carried out using a modified 
procedure as mentioned in the “Experimental section”, and 
both native and loaded polymeric micelles were character-
ized via transmission electron microscopy and DLS. Based 
on DLS measurements, the native polymeric nanoparticles 
were found to have an average diameter of 24 nm as 
demonstrated in Figure), while the electroactive complex 
(ferrocene)-encapsulated polymeric nanoparticles exhibited 
a significant increase in diameter with an average value of 
40 nm as revealed in Figure 2.
The increase in micelles size can be attributed to the 
amount of ferrocene encapsulated within them. The ferrocene 
concentration inside the micelles was determined based on 
the average molecular mass difference (∆m =4.8×10-17 g) 
between the micelle loaded with the ferrocene (m
2
) and the 
Scheme 1 Poly(ethylene glycol-b-trimethylsilyl methacrylate) structure and the representation of self-assembly process of the polymer into micelles (polymeric 
nanoparticles).
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micelle without the ferrocene, that is, native micelle (m
1
) 
that was derived from SLS, and the molecular weight of one 
dye molecule which was 4.4×10-22 g. Thus, we estimated 
the number of dye molecules that can be encapsulated inside 
one micelle with an Rh of 37 nm to be ~110,000. As a result, 
the release of such a concentration of the ferrocene molecules 
into the solution provided important signal amplification for 
probing the antigen–antibody binding event.
Ferrocene encapsulation and leakage investigations were 
established by the toxicity study of the ferrocene-encapsulated 
nanoparticles, which were incubated with mouse embryonic 
stem cells (due to their sensitivity). When free ferrocene 
(40 μM) was in direct contact with the cells, the cell death 
was observed in 3 days. However, upon mixing the same 
type of cells with ferrocene (400 μM) encapsulated within 
polymeric micelles, the cell colony growth stayed normal 
for 3 days (data not shown). The results suggested that the 
ferrocene molecules were encapsulated and kept inside the 
micelles and were completely isolated from the cells.
assessment of polymeric nanoparticles’ 
targeting of cancer cells
To evaluate the ability of anti-MUC1-bioconjugated micelles 
to target cancer cells and confirm its selectivity toward 
MUC1-expressing cells, we loaded the polymeric nano-
particles with 1-methylpyrene (fluorescent dye). To target 
MUC1-expressing cells, fluorophore-loaded micelles were 
bioconjugated with the anti-MUC1. We used the MCF-7 cell 
line, which displayed the highest levels of MUC1 expres-
sion, and the mouse bone marrow stroma S17 cell line as a 
negative control (Figure 3).
Anti-MUC1-bioconjugated and non-conjugated 
fluorophore-loaded micelles were incubated for different 
periods of time with each cell line, and the incorporation 
Figure 1 (A) Dynamic light scattering and (B) transmission electron microscopy of unloaded polymeric nanoparticles (bar scale, 50 nm).
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Figure 2 (A) Dynamic light scattering and (B) transmission electron microscopy of ferrocene-loaded polymeric nanoparticles (bar scale, 50 nm).
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of 1-methylpyrene was assessed using a fluorescence 
microscope. Thus, MCF-7 cell incubation with anti-MUC1-
bioconjugated micelles resulted in a higher percentage 
of fluorescent cells than incubation with non-conjugated 
micelles (Figure 4).
In contrast, incubation of S17 cells with anti-MUC1-
bioconjugated micelles did not result in a higher proportion 
of fluorescent S17 cells, as compared to non-conjugated 
micelles (Figure 5). Jointly, these results revealed the 
selectivity of these bioconjugated nanoparticles toward 
MUC1-expressing cells and also established the fact that 
these micelles released their contents within cells.
The goal of the next experiment was to examine if anti-
human MUC1 polymeric nanoparticles were able to specifi-
cally attach to MDA-MB-468 cells, even when these cells 
were mixed in inferior number with S17 mouse cells. Thus, 
S17 and MDA-MB-468 cells were cultured in a 5:1 ratio. 
Then, the mixed culture was incubated with anti-MUC1 
polymeric micelles for a period of 1 h. After that, the mixed 
culture was washed several times with PBS buffer before 
observation under the fluorescence microscope.
We witnessed that the MDA-MB-468 cells, which 
displayed round morphology (Figure 6B), incorporated far 
more fluorescence dye (1-methylpyrene) compared to S17 
cells, which displayed elongated morphology (Figure 6C) 
with almost no fluorescence (Figure 6A). This clearly dem-
onstrates the high selectivity of these bioconjugated particles 
toward MUC1-expressing cells.
Figure 3 Detection of MUc1 expression in s17, MDa-MB-468, McF-7, and hela 
cell lines by real-time polymerase chain reaction.
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Figure 4 (A) Testing of affinity of 1-methylpyrene-loaded nanoparticles (without anti-MUC1) and (B) c595 anti-MUc1 1-methylpyrene-loaded nanoparticles toward 
McF-7 cells.
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Figure 5 Testing of affinity of C595 anti-MUC1 1-methylpyrene-loaded nanoparticles toward S17 cells (control experiment).
1DQRSDUWLFOHVZLWKDQWLERG\08&&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Figure 6 Testing of affinity of anti-MUC1 1-methylpyrene-loaded nanoparticles toward MDA-MB-468 breast cancer cells. (B) MDa-MB-468 and (C) s17 cells were seeded at 
a ratio of 1:5 and incubated for 1 h with anti-MUc1-bioconjugated micelles. (A) After incubation and cell fixation, the increased uptake of anti-MUC1 micelles by the human 
MUc1-expressing MDa-MB-468 cells was evident.
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Detection of polymeric micelle-based 
bioassay for MUc1 using ferrocene
CV is a powerful analytical method that can reveal vital 
information about the oxidation/reduction processes of an 
element in a compound as well as its stability under certain 
conditions. CV can also be used to establish the diffusion 
coefficient of an analyte, the electron transfer kinetics, the 
electron stoichiometry of a system, and the precise reduction 
potential of any compound, which can be used as identifica-
tion means. To perform CV, typically a potentiostat and a 
three-electrode cell are utilized to first apply a linear potential 
scan from potential E
1
 to potential E
2
, followed by a reverse 
scan back to potential E
1
. Since the FeIII/II redox couple of fer-
rocene (η5-C
5
H
5
)
2
Fe is a good illustration of a well-behaving 
electrochemically reversible system that easily undergoes one 
electron oxidation to form ferricenium (η5-C
5
H
5
)
2
Fe+ cation, 
this is frequently used as a reference to determine standard 
reduction potentials of redox-active species. Additionally, 
since in a Nernstian system the current is directly propor-
tional to concentration, the concentration of ferrocene can be 
determined by engendering a calibration curve of current vs 
concentration. Due to these features, ferrocene is indirectly 
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used as an electrochemical indicator to report the presence 
of cancer marker (MUC1) within the cell lysate.
In this investigation, two different antibodies were used 
against MUC1, C595 and SM3, which, respectively, rec-
ognize the peptide epitope ARG-PRO-ALA-PRO and the 
epitope within the VNTR tandem repeat peptide, which is 
exposed only in underglycosylated MUC1 protein.32
In our assay, we used magnetic beads conjugated to 
SM3 antibody to capture the MUC1 at different concen-
trations of MCF-7 cell lysis solution (1,000, 100, 10, and 
1 cell/mL). Collecting the magnetic beads from the cell 
lysis solution via an external magnet was followed by 
washing off nonspecifically bound biomolecules using 
PBS buffer. Then, the C595-labeled and loaded micelles 
were incubated with the sandwich magnetic beads (beads–
SM3–MUC1) for 1 h, followed by washing off unbound 
bioconjugated micelles, and a sandwich of micelle–bio-
marker–magnetic beads was obtained. After decreasing the 
pH of the sandwich solution, anodic (E
pa
) and cathodic (E
pc
) 
peak potentials of ferrocene (Fe(C
2
H
5
)
2
+/Fe(C
5
H
5
)) were 
obtained, indicating the presence of ferrocene molecules 
that were released from the micelle–biomarker–magnetic 
beads sandwich (Figure 7).
In this test, the intensity of the signal depends on the 
amount of ferrocene released into the medium. Since our 
micelles can encapsulate a large amount of ferrocene, this 
new bioassay enables us to detect the presence of the MUC1 
biomarker within 10 cells/mL (Figure 8A) in less than 1 min. 
As a result, the strong signal of FeIII/II redox couple clearly 
illustrates the sensitivity and selectivity of this new bioas-
say toward low-abundance cancer biomarker candidate via 
signal amplification. The precision and the reproducibility 
of our assay were confirmed by measuring the relative stan-
dard deviation or coefficient of variation. Based on current 
intensity collected from repeating our new assay with four 
times of the sample containing 10 cells/mL, it was deter-
mined that the coefficient of variation was no more than 
0.23% (Table 1).
A couple of control experiments were executed to ensure 
no false positives or signal interferences were obtained: 
1) Nearly no electrochemical signals were observed when 
sandwich magnetic beads (beads–SM3–MUC1) were 
Figure 7 schematic of the detection process of the new bioassay.
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Figure 8 Ferrocene cyclic voltammetry readings of the event of binding between loaded polymeric micelle and MUc1 biomarker. A: Detection of breast cancer biomarker 
MUc1 using McF-7 breast cancer cells and ferrocene-loaded micelles. B: control experiment 1: Detection of breast cancer biomarker MUc1 using s17 cell line instead of 
McF-7 breast cancer cells. C: control experiment 2: The detection step is performed using plain loaded polymeric micelles (no antibody is present on the surface).
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Table 1 relative standard deviation
Mean 1.09×10-7
standard deviation 0.0024×10-7
Coefficient of variation 0.23%
incubated with plain loaded polymeric micelles (no antibody 
on the surface), indicating the absence of nonspecific interac-
tions between the plain micelles and the magnetic beads sand-
wich (Figure 8C). 2) Since S17 (mouse bone marrow stroma) 
cells have no MUC, MDA-MB-468 cell lysis solution was 
replaced with S17 cell lysis solution (1,000 cells/mL) and then 
incubated with C595-labeled and ferrocene-loaded polymeric 
micelles. This was followed by washing off unbound biocon-
jugated micelles, and again, no electrochemical signal for the 
ferrocene molecules was recorded (Figure 8B). Together, 
these observations clearly indicate the high selectivity of this 
new bioassay toward MUC1 biomarker.
Conclusion
Since pH-sensitive polymeric nanoparticles have proven to 
be efficient and stable carriers (great stability and leakage 
proof), we encapsulated ferrocene molecules. The encapsu-
lated ferrocene molecules were used as tracers to probe the 
event of binding of the antibody with its antigen. Using this 
new concept, we were able to detect our target, the MUC1, 
within 10 cells/mL in less than 1 min, by first releasing 
the encapsulated ferrocene molecules into the solution via 
decreasing the pH and then measuring the electrochemi-
cal signal (current intensity) using CV. Consequently, we 
developed an extremely selective and sensitive bioassay 
with signal amplification capability. This new bioassay has 
numerous advantages over the existing techniques: 1) The 
amplification process allows the detection of low-abundance 
biomarkers, where every single event of binding between the 
antibody and antigen is indicated by hundreds of thousands 
of ferrocene molecules that are released into the solution. 
2) These new polymeric nanoparticles have great stability and 
leakage proof. 3) This newly developed bioassay will open 
the door to new cheap, robust, and disposable electrochemi-
cal biosensors for cancer biomarker detection, with smaller 
sample volume requirements.
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